Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 2.46 Billion | USD 14.71 Billion | 19.60% | 2024 |
FrequentlyAsked Questions
Next generation sequencing (NGS) Ribonucleic Acid (RNA)-sequencing is an advanced sequencing technology used for identifying and analyzing RNA in a research sample.
The global NGS-based RNA-sequencing market is expected to be driven by the rising applications of the technology in cancer research.
According to study, the global NGS-based RNA-sequencing market size was worth around USD 2.46 billion in 2024 and is predicted to grow to around USD 14.71 billion by 2034.
The CAGR value of the NGS-based RNA-sequencing market is expected to be around 19.60% during 2025-2034.
The global NGS-based RNA-sequencing market will be led by North America during the forecast period.
The global NGS-based RNA-sequencing market is led by players like Pacific Biosciences of California, Inc., Illumina, Inc., 10x Genomics, Inc., GATC Biotech AG, Thermo Fisher Scientific Inc., Eurofins Scientific, Macrogen, Inc., Agilent Technologies, Inc., Takara Bio Inc., Oxford Nanopore Technologies Ltd., Novogene Corporation, PerkinElmer, Inc., BGI Genomics Co., Ltd., QIAGEN N.V., and Bio-Rad Laboratories, Inc.
The report explores crucial aspects of the NGS-based RNA-sequencing market, including a detailed discussion of existing growth factors and restraints, while browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed